MSDS   | : | Dibenzo(def,p)chrysene
| CAS   | : | 191-30-0 | SYNONYMS   | : | * BA 51-090462
* DB(a,l)P
* Dibenzo(a,d)pyrene
* Dibenzo(a,l)pyrene
* 1,2:3,4-Dibenzopyrene
* 1,2,9,10-Dibenzopyrene
* 2,3:4,5-Dibenzopyrene
* 1,2,3,4-Dibenzpyrene
* 4,5,6,7-Dibenzpyrene
|
| |
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : HO6125000
CHEMICAL NAME : Dibenzo(def,p)chrysene
CAS REGISTRY NUMBER : 191-30-0
BEILSTEIN REFERENCE NO. : 2054068
REFERENCE : 4-05-00-02803 (Beilstein Handbook Reference)
LAST UPDATED : 199801
DATA ITEMS CITED : 16
MOLECULAR FORMULA : C24-H14
MOLECULAR WEIGHT : 302.38
WISWESSER LINE NOTATION : L D66 K666 B6 2AB A&J
COMPOUND DESCRIPTOR : Tumorigen
Mutagen
SYNONYMS/TRADE NAMES :
* BA 51-090462
* DB(a,l)P
* Dibenzo(a,d)pyrene
* Dibenzo(a,l)pyrene
* 1,2:3,4-Dibenzopyrene
* 1,2,9,10-Dibenzopyrene
* 2,3:4,5-Dibenzopyrene
* 1,2,3,4-Dibenzpyrene
* 4,5,6,7-Dibenzpyrene
*** HEALTH HAZARD DATA ***
** TUMORIGENIC DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 96761 ug/kg
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Skin and Appendages - tumors
REFERENCE :
JCROD7 Journal of Cancer Research and Clinical Oncology. (Springer-Verlag
New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93-
1979- Volume(issue)/page/year: 115,67,1989
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Administration onto the skin
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 890 mg/kg/37W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Skin and Appendages - tumors
Tumorigenic - tumors at site of application
REFERENCE :
PRLBA4 Proceedings of the Royal Society of London, Series B: Biological
Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76-
1905- Volume(issue)/page/year: 123,343,1937
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 48 mg/kg/4W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
NATWAY Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000
Berlin 33, Fed. Rep. Ger.) V.1- 1913- Volume(issue)/page/year:
55,43,1968
TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 72 mg/kg/9W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
COREAF Comptes Rendus Hebdomadaires des Seances, Academie des Sciences.
(Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV.
Volume(issue)/page/year: 258,3387,1964
** MUTATION DATA **
TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 5 nmol/plate
REFERENCE :
CRTOEC Chemical Research in Toxicology. (American Chemical Soc.,
Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC
20037) V.1- 1988- Volume(issue)/page/year: 3,580,1990
TYPE OF TEST : DNA adduct
TEST SYSTEM : Human Mammary gland
DOSE/DURATION : 500 umol/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 17,1769,1996
TYPE OF TEST : Mutation in mammalian somatic cells
TEST SYSTEM : Human Lymphocyte
DOSE/DURATION : 310 pmol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 342,9,1995
TYPE OF TEST : Morphological transformation
TEST SYSTEM : Rodent - mouse Embryo
DOSE/DURATION : 100 nmol/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 18,1973,1997
TYPE OF TEST : DNA adduct
TEST SYSTEM : Rodent - mouse Embryo
DOSE/DURATION : 100 ug/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 18,1973,1997
*** REVIEWS ***
IARC Cancer Review:Animal Sufficient Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 32,343,1983
IARC Cancer Review:Human No Adequate Data
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 32,343,1983
IARC Cancer Review:Group 2B
IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49
Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year:
7,56,1987
TOXICOLOGY REVIEW
85DHAX "Medical and Biologic Effects of Environmental Pollutants Series,"
Washington, DC, National Academy of Sciences, 1972-77
Volume(issue)/page/year: Pc,4,1972
*** OCCUPATIONAL EXPOSURE LIMITS ***
OEL-FRANCE;Carcinogen JAN 1993
*** STATUS IN U.S. ***
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat
NTP 7th Annual Report on Carcinogens, 1992 : anticipated to be carcinogen
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,9-acetyl-7-chloro-3-methyl-
| 62538-90-3 |
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,9-acetyl-3-methyl-
| 62538-94-7 |
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,6-chloro-3-methyl-, hydrochloride
| 62538-82-3 |
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,7-chloro-3-methyl-, hydrochloride
| 62538-83-4 |
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,3-methyl-, hydrochloride
| 62538-81-2 |
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,3-methyl-9-propionyl-
| 62538-91-4 |
Dibenz(b,f)imidazo(1,2-d)(1,4)oxazepine, 3-methyl-,hydrochloride
| 62538-79-8 |
Dibenz(b,f)imidazo(1,2-d)(1,4)thiazepine
| 62538-84-5 |
3,12-Diaza-6,9-diazoniadispiro(5.2.5.2)hexadecane,3,12-bis(4-(4-(bis(2-chloroethyl)amino)phenyl)-1-oxobutyl)-, dichloride
| 95461-38-4 |
Dibenz(b,f)imidazo(1,2-d)(1,4)thiazepine, 3-methyl-,hydrochloride
| 62538-80-1 |
Dibenz(c,f)indeno(1,2,3-ij)(2,7)naphthyridine
| 193-40-8 |
10H-Dibenz(b,e)iodinium, 3,7-bis(dimethylamino)-,salt with N,N'-1,2-ethanediylbis(N-(carboxymethyl)glycine) (1:1)
| 143578-51-2 |
10H-Dibenz(b,e)iodinium, 3,7-bis(dimethylamino)-,salt with 2-hydroxy-1,2,3- propanetricarboxylic acid(1:1)
| 111950-71-1 |
3H-Dibenz(f,ij)isoquinoline-2,7-dione,4-bromo-3-methyl-
| 111950-71-1 |
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine,3a,12b-dihydro-3-phenyl-
| 85008-74-8 |
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine-8-ethanamine,N,N-dimethyl-3-phenyl-, monohydrochloride
| 85008-92-0 |
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine, 3-phenyl-
| 85008-92-0 |
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine-8-propanamine,N,N-dimethyl-3-phenyl-, monohydrochloride
| 85008-88-4 |
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine-8-propanamine,3-phenyl-N,N,beta-trimethyl-, monohydrochloride
| 85008-93-1 |
3,12-Diaza-6,9-diazoniadispiro(5.2.5.2)hexadecane,3,12-bis(3-bromo-2-methyl-1-oxopropyl)-, dichloride,hydrate
| 95461-33-9 |
Dibenzo(a,e)aceanthrylene-1,2-diol,1,2,3,4-tetrahydro-3,4-epoxy-
| 95461-33-9 |
Dibenzo(a,e)aceanthrylene-10,11-diol,10,11,12,13-tetrahydro-12,13-epoxy-
| 95461-33-9 |
6H-Dibenzo(b,e)azepin-6-one,5,11-dihydro-11-ethoxy-5-methyl-
| 88124-27-0 |
Dibenzo(a,g)biphenylene-3,9-diol,5,6,6a-alpha,6b-beta,11,12,12a-beta,12b-alpha-octahydro-
| 88124-27-0 |
Dibenzo(c,g)carbazole
| 28641-62-5 |
7H-Dibenzo(a,g)carbazole
| 207-84-1 |
13H-Dibenzo(a,i)carbazole
| 239-64-5 |
7H-Dibenzo(c,g)carbazole
| 194-59-2 |
7H-Dibenzo(a,g)carbazole, 12,13-dihydro-
| 63077-00-9 |
7H-Dibenzo(c,g)carbazole, 5,9-dimethyl-
| 88193-04-8 |
3,12-Diaza-6,9-diazoniadispiro(5.2.5.2)hexadecane,3,12-bis(3-bromo-1-oxopropyl)-, dibromide
| 86641-77-2 |
7H-Dibenzo(a,g)carbazole, 2-methyl-
| 63918-57-0 |
7H-Dibenzo(c,g)carbazole, N-methyl-
| 27093-62-5 |
7H-Dibenzo(c,g)carbazole, 3-methyl-
| 101021-43-6 |
1H-Dibenzo(c,g)carbazol-2-ol
| 101021-43-6 |
1H-Dibenzo(c,g)carbazol-3-ol
| 101021-43-6 |
1H-Dibenzo(c,g)carbazol-4-ol
| 101021-43-6 |
7H-Dibenzo(c,g)carbazol-2-ol
| 78448-08-5 |
7H-Dibenzo(c,g)carbazol-3-ol
| 78448-07-4 |
7H-Dibenzo(c,g)carbazol-4-ol
| 78448-09-6 |
7H-Dibenzo(c,g)carbazol-13c-ol
| 78448-09-6 |
3,12-Diaza-6,9-diazoniadispiro(5.2.5.2)hexadecane,3,12-bis(3-bromo-1-oxopropyl)-, dichloride
| 86641-76-1 |
7H-Dibenzo(c,g)carbazol-13c-ol, 6a,13c-dihydro-
| 86641-76-1 |
Dibenzo(b,def)chrysene
| 189-64-0 |
Dibenzo(def,mno)chrysene
| 191-26-4 |
Dibenzo(def,p)chrysene
| 191-30-0 |
Dibenzo(def,mno)chrysene, 6-bromomethyl-
| 191-30-0 |
Dibenzo(b,def)chrysene-7-carboxaldehyde
| 63040-54-0 |
Dibenzo(def,mno)chrysene-12-carboxaldehyde
| 63040-55-1 |
Dibenzo(def,p)chrysene-10-carboxaldehyde
| 2869-59-2 |
|
|